Company Filing History:
Years Active: 2019
Title: **Innovative Contributions of Quanbing Han in Ischemic Condition Treatment**
Introduction
Quanbing Han, an inventive mind stemming from Taipa, MO, has made significant strides in the medical field with his innovative approach to treating ischemic conditions. His work, underscored by a robust patent, reflects a deep commitment to advancing healthcare solutions.
Latest Patents
Quanbing Han holds a patent for a groundbreaking method of treating subjects suffering from ischemic conditions, particularly ischemic heart disease. The patent focuses on administering an effective amount of a carbohydrate composition extracted from natural sources. This invention not only offers exceptional cardioprotective effects but also serves as a promising treatment option for preventing ischemia-reperfusion injuries. The methodology emphasizes the protection of cells against hypoxia and reoxygenation-induced cell death, making a substantial impact in the realm of medical treatments.
Career Highlights
Han is currently affiliated with the Macau University of Science and Technology, where he contributes to research and innovation within the institution. His career is marked by his dedication to finding effective treatments for various health conditions, reflecting both his expertise and passion for medical research.
Collaborations
Among Han's collaborators are Hua Zhou and Yihan Zuo, both of whom contribute to the research and development efforts associated with his innovative work. Their collective expertise enhances the quality and reach of the projects they undertake, as they aim to improve therapeutic outcomes for patients with ischemic conditions.
Conclusion
In summary, Quanbing Han stands out as a significant inventor in the medical research community, particularly for his advancements in treating ischemic conditions. His patented methods not only showcase his innovation but also hint at a promising future for therapeutic interventions in cardiovascular health.